Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
RPRX | Royalty Pharma plc | Legorreta Pablo G. | CEO, Chairman of the Board | Jun 28, 2023 | Buy | $29.51 | 130,000 | 3,836,768 | 600,000 | Jun 28, 2023, 04:01 PM | |
RPRX | Royalty Pharma plc | Legorreta Pablo G. | CEO, Chairman of the Board | Jun 13, 2023 | Buy | $32.78 | 45,000 | 1,474,902 | 470,000 | Jun 13, 2023, 04:01 PM | |
RPRX | Royalty Pharma plc | Legorreta Pablo G. | CEO, Chairman of the Board | Jun 12, 2023 | Buy | $33.00 | 45,000 | 1,484,946 | 425,000 | Jun 13, 2023, 04:01 PM | |
RPRX | Royalty Pharma plc | Legorreta Pablo G. | CEO, Chairman of the Board | May 24, 2023 | Buy | $32.25 | 150,000 | 4,837,440 | 380,000 | May 24, 2023, 06:45 PM | |
RPRX | Royalty Pharma plc | Legorreta Pablo G. | CEO, Chairman of the Board | May 16, 2023 | Buy | $33.57 | 160,388 | 5,383,728 | 160,388 | May 17, 2023, 06:41 PM | |
RPRX | Royalty Pharma plc | Legorreta Pablo G. | CEO, Chairman of the Board | May 17, 2023 | Buy | $32.94 | 69,612 | 2,293,096 | 230,000 | May 17, 2023, 06:41 PM | |
EPZM | Epizyme, Inc. | Legorreta Pablo G. | Director | Jan 31, 2022 | Buy | $1.50 | 22,666,667 | 34,000,001 | 31,833,334 | Feb 01, 2022, 04:17 PM | |
RPRX | Royalty Pharma plc | Legorreta Pablo G. | CEO, Chairman of the Board | Jun 18, 2020 | Buy | $28.00 | 20,000 | 560,000 | 10,000 | Jun 22, 2020, 09:55 PM | |
EPZM | Epizyme, Inc. | Legorreta Pablo G. | Director | Feb 11, 2020 | Option Exercise | $20.00 | 2,500,000 | 50,000,000 | 9,166,667 | Feb 13, 2020, 06:47 PM |